Table 1.
Characteristics of the respondents.
| n | % | |
|---|---|---|
| Gender | ||
| Male | 796 | 98.03% |
| Female | 16 | 1.97% |
| Age | ||
| <40 | 285 | 35.10% |
| 40–59 | 515 | 63.42% |
| ≥60 | 12 | 1.48% |
| Years of clinical practice | ||
| <15 | 299 | 36.82% |
| 15–29 | 404 | 49.75% |
| ≥30 | 109 | 13.42% |
| Level of healthcare institute | ||
| 3 | 637 | 78.45% |
| 2 | 174 | 21.43% |
| 1 | 3 | 0.37% |
| Education background | ||
| Doctor | 195 | 24.01% |
| Master | 262 | 32.27% |
| Bachelor | 345 | 42.49% |
| College | 10 | 1.23% |
| Professional title | ||
| Senior title | 233 | 28.69% |
| Vice-senior title | 299 | 36.82% |
| Middle title | 119 | 14.66% |
| Primary title | 61 | 7.51% |
| Preferred guideline developer | ||
| Chinese Medical Association (CMA) | 591 | 72.78% |
| European Association of Urology (EAU) | 495 | 60.96% |
| American Urological Association (AUA) | 396 | 48.77% |
| National Comprehensive Cancer Network (NCCN) | 298 | 36.70% |
| Canadian Urological Association (CUA) | 267 | 32.88% |
| Chinese Medical Doctor Association (CMDA) | 236 | 29.06% |
| National Institute for Health and Care Excellence (NICE) | 86 | 10.59% |
| Chinese Research Hospital Association (CRHA) | 51 | 6.28% |
| Have participated in guideline development | 87 | 10.71% |
| Recognized the positive function of guidelines | 802 | 98.77% |